We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+0.92%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.16B
AUM Growth
-$38.5M
Cap. Flow
-$16.1M
Cap. Flow %
-1.39%
Top 10 Hldgs %
4.12%
Holding
2,179
New
583
Increased
522
Reduced
502
Closed
562

Sector Composition

Rank Sector Weight
1 Healthcare 16.3%
2 Technology 15.76%
3 Financials 13.46%
4 Industrials 12.71%
5 Consumer Discretionary 10.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EM
1601
DELISTED
Smart Share Global Ltd
EM
$19K ﹤0.01%
+16,362
New +$21.8K
SKYE icon
1602
Skye Bioscience
SKYE
$18.3M
$17K ﹤0.01%
+22,877
New +$33.4K
CGTX icon
1603
Cognition Therapeutics
CGTX
$96.7M
$16K ﹤0.01%
11,843
-184,514
-94% -$299K
WWR icon
1604
Westwater Resources
WWR
$97.5M
$16K ﹤0.01%
21,063
-115,237
-85% -$143K
ARAY icon
1605
Accuray
ARAY
$34M
$15K ﹤0.01%
18,139
-62,562
-78% -$78.1K
PAVM icon
1606
PAVmed
PAVM
$33.9M
$15K ﹤0.01%
+2,197
New +$25.1K
PRTS icon
1607
CarParts.com
PRTS
$54.7M
$15K ﹤0.01%
3,083
-53,297
-95% -$298K
SUNE
1608
SUNation Energy
SUNE
$10.8M
$15K ﹤0.01%
+15,035
New +$20.2K
BCDA icon
1609
BioCardia
BCDA
$14.6M
$14K ﹤0.01%
+11,303
New +$15.4K
PZG icon
1610
Paramount Gold Nevada
PZG
$124M
$14K ﹤0.01%
+11,338
New +$13.1K
ATER icon
1611
Aterian
ATER
$5.37M
$13K ﹤0.01%
18,137
-1,246
-6% -$1.09K
KUST
1612
Kustom Entertainment Inc
KUST
$759K
$13K ﹤0.01%
+1,345
New +$29.7K
MBIO icon
1613
Mustang Bio
MBIO
$4.55M
$13K ﹤0.01%
+12,834
New +$16.9K
RLYB icon
1614
Rallybio
RLYB
$85.8M
$13K ﹤0.01%
+2,413
New +$12.4K
TOUR
1615
Tuniu
TOUR
$55.6M
$13K ﹤0.01%
+2,060
New +$16.2K
MYPS icon
1616
PLAYSTUDIOS Inc
MYPS
$90.1M
$11K ﹤0.01%
16,713
-70,286
-81% -$54.7K
AA icon
1617
Alcoa
AA
$13.2B
-13,401
Closed -$441K
AAT
1618
American Assets Trust
AAT
$1.4B
-59,791
Closed -$1.22M
ABCL icon
1619
AbCellera Biologics
ABCL
$2.12B
-212,518
Closed -$1.07M
ABG icon
1620
Asbury Automotive
ABG
$3.85B
-1,739
Closed -$425K
ABOS icon
1621
Acumen Pharmaceuticals
ABOS
$176M
-32,103
Closed -$55K
ACMR icon
1622
ACM Research
ACMR
$5.79B
-11,423
Closed -$447K
ACTG icon
1623
Acacia Research
ACTG
$470M
-64,433
Closed -$209K
ADBE icon
1624
Adobe
ADBE
$105B
-4,349
Closed -$1.53M
ADSK icon
1625
Autodesk
ADSK
$52.6B
-761
Closed -$242K

Similar funds

GSA Capital Partners's Q4 2025 Portfolio in Review

As of Q4 2025, GSA Capital Partners held 2,179 positions worth $1.16B, down 3.2% from $1.2B the previous quarter. Its ten largest holdings account for 4.1% of the portfolio.

GSA Capital Partners's Q4 2025 filing shows 583 new, 522 increased, 502 reduced and 562 closed positions. Its largest new stake was iShares Floating Rate Bond ETF: 137,329 shares worth $6.99M. The largest sale was Nuvation Bio, an estimated $6.32M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

  • GSA Capital Partners's largest Q4 2025 buy was iShares Floating Rate Bond ETF: 137,329 shares worth $6.99M.
  • GSA Capital Partners added most to Remitly in Q4 2025, an estimated $4.91M increase.
  • GSA Capital Partners's biggest Q4 2025 reduction was Nuvation Bio, cutting an estimated $6.32M.
  • GSA Capital Partners fully exited Jefferies Financial Group in Q4 2025, selling an estimated $3.77M.
  • GSA Capital Partners's ten largest holdings make up 4.1% of its $1.16B portfolio in Q4 2025.
  • GSA Capital Partners opened 583 new positions and closed 562 in Q4 2025.
  • GSA Capital Partners's portfolio value fell 3.2% quarter-over-quarter to $1.16B.

Based on GSA Capital Partners's 13F filing for Q4 2025, filed 6 Feb 2026.